Trade Mark Journal No.2025/037 12 September 2025
WO0000001872393 (5)
Office of origin: United States of America
Date of International Registration:15 July 2025
Date of designation in the UK:
15 July 2025

International priority date claimed: 15 January 2025
(United States of America)
(98964211)
- Class 5
- Pharmaceutical and biologic preparations for the prevention and treatment of organ rejection.
Stellon Biotech Inc.
Representative: Hillary Maynard Polsinelli PC, PO Box 140310, Kansas City MO 64114-0310, UNITED STATES OF AMERICA